Start:
March 1, 2021
End:
June 2024
Enrollment:
200
This study will evaluate use of the tau tracer [18F]MK-6240 to image the brains of individuals from families with a known autosomal dominant Alzheimer's disease mutation. Participants will undergo positron emission tomography (PET) imaging of the brain to measure the level of tau, a protein found in a harmful form in the brain of people with Alzheimer's disease.
Minimum Age: 18 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Missouri | |
---|---|
Washington University School of Medicine
Saint Louis,
MO
63110
Recruiting
Jasmin Chua, MS |
Lead: Washington University School of Medicine
Source: ClinicalTrials.gov ID: NCT04104659
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health